182 related articles for article (PubMed ID: 15322133)
1. Prevention of Alzheimer's disease-associated Abeta aggregation by rationally designed nonpeptidic beta-sheet ligands.
Rzepecki P; Nagel-Steger L; Feuerstein S; Linne U; Molt O; Zadmard R; Aschermann K; Wehner M; Schrader T; Riesner D
J Biol Chem; 2004 Nov; 279(46):47497-505. PubMed ID: 15322133
[TBL] [Abstract][Full Text] [Related]
2. beta-Sheet ligands in action: KLVFF recognition by aminopyrazole hybrid receptors in water.
Rzepecki P; Schrader T
J Am Chem Soc; 2005 Mar; 127(9):3016-25. PubMed ID: 15740139
[TBL] [Abstract][Full Text] [Related]
3. Rational design of β-sheet ligands against Aβ42-induced toxicity.
Hochdörffer K; März-Berberich J; Nagel-Steger L; Epple M; Meyer-Zaika W; Horn AH; Sticht H; Sinha S; Bitan G; Schrader T
J Am Chem Soc; 2011 Mar; 133(12):4348-58. PubMed ID: 21381732
[TBL] [Abstract][Full Text] [Related]
4. Real-Time Monitoring of Alzheimer's-Related Amyloid Aggregation via Probe Enhancement-Fluorescence Correlation Spectroscopy.
Guan Y; Cao KJ; Cantlon A; Elbel K; Theodorakis EA; Walsh DM; Yang J; Shah JV
ACS Chem Neurosci; 2015 Sep; 6(9):1503-8. PubMed ID: 26212450
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
[TBL] [Abstract][Full Text] [Related]
6. Hybridization of an Aβ-specific antibody fragment with aminopyrazole-based β-sheet ligands displays striking enhancement of target affinity.
Hellmert M; Müller-Schiffmann A; Peters MS; Korth C; Schrader T
Org Biomol Chem; 2015 Mar; 13(10):2974-9. PubMed ID: 25613910
[TBL] [Abstract][Full Text] [Related]
7. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure.
Goldblatt G; Cilenti L; Matos JO; Lee B; Ciaffone N; Wang QX; Tetard L; Teter K; Tatulian SA
FEBS J; 2017 May; 284(9):1355-1369. PubMed ID: 28294556
[TBL] [Abstract][Full Text] [Related]
8. α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.
Shea D; Hsu CC; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; Varani G; Link CD; Mullan M; Daggett V
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8895-8900. PubMed ID: 31004062
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation.
Hoyer W; Grönwall C; Jonsson A; Ståhl S; Härd T
Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5099-104. PubMed ID: 18375754
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
Sun Y; Qian Z; Wei G
Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
[TBL] [Abstract][Full Text] [Related]
11. [Cell-surface Initial Aggregation Process of Amyloid-β Peptides Studied by Fluorescence Correlation Spectroscopy].
Yano Y
Yakugaku Zasshi; 2021; 141(6):825-829. PubMed ID: 34078789
[TBL] [Abstract][Full Text] [Related]
12. Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide Aβ(1-42).
Ryan TM; Friedhuber A; Lind M; Howlett GJ; Masters C; Roberts BR
J Biol Chem; 2012 May; 287(20):16947-54. PubMed ID: 22461629
[TBL] [Abstract][Full Text] [Related]
13. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.
Bokvist M; Lindström F; Watts A; Gröbner G
J Mol Biol; 2004 Jan; 335(4):1039-49. PubMed ID: 14698298
[TBL] [Abstract][Full Text] [Related]
14. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of beta-amyloid oligomer-aggregates by ion mobility mass spectrometry and electron spin resonance spectroscopy.
Ionuţ Iuraşcu M; Cozma C; Tomczyk N; Rontree J; Desor M; Drescher M; Przybylski M
Anal Bioanal Chem; 2009 Dec; 395(8):2509-19. PubMed ID: 19838688
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effects of pH, Cu+2 and sheet breakers on aggregation of amyloid peptides.
Beking K; Hao X; Basak S; Basak A
Protein Pept Lett; 2005 Feb; 12(2):197-202. PubMed ID: 15723646
[TBL] [Abstract][Full Text] [Related]
17. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: Abeta association kinetics at endosomal pH.
Gorman PM; Yip CM; Fraser PE; Chakrabartty A
J Mol Biol; 2003 Jan; 325(4):743-57. PubMed ID: 12507477
[TBL] [Abstract][Full Text] [Related]
18. Modulation of aggregate size- and shape-distributions of the amyloid-beta peptide by a designed beta-sheet breaker.
Nagel-Steger L; Demeler B; Meyer-Zaika W; Hochdörffer K; Schrader T; Willbold D
Eur Biophys J; 2010 Feb; 39(3):415-22. PubMed ID: 19238376
[TBL] [Abstract][Full Text] [Related]
19. Modulation of fibril formation by a beta-sheet breaker peptide ligand: an electrochemical approach.
Veloso AJ; Kerman K
Bioelectrochemistry; 2012 Apr; 84():49-52. PubMed ID: 21967982
[TBL] [Abstract][Full Text] [Related]
20. Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes.
Nardo L; Re F; Brioschi S; Cazzaniga E; Orlando A; Minniti S; Lamperti M; Gregori M; Cassina V; Brogioli D; Salerno D; Mantegazza F
Biochim Biophys Acta; 2016 Apr; 1860(4):746-56. PubMed ID: 26774643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
